Amiodarone-Associated Optic Neuropathy: A Nationwide Study.

Area of Science:

• Ophthalmology
• Cardiology
• Pharmacology

Background:

• Amiodarone is a widely used antiarrhythmic drug.
• Optic neuropathy is a potential adverse effect of amiodarone therapy.

Purpose of the Study:

• To determine if amiodarone treatment is associated with an increased risk of developing optic neuropathy.
• To identify patient subgroups or treatment characteristics that may influence this risk.

Main Methods:

• Retrospective population-based cohort study utilizing the Taiwan National Health Insurance Research Database.
• Inclusion of 6175 amiodarone-treated patients and 24,700 matched controls.
• Cox multivariate regression analysis to assess the association between amiodarone and optic neuropathy, with stratification by gender and analysis of treatment duration and dosage.

Main Results:

• Amiodarone-treated patients exhibited a 2-fold increased risk of optic neuropathy (HR, 2.09).
• The risk was significantly higher in male patients (HR, 3.05) compared to female patients.
• A trend towards increased risk was observed with longer amiodarone treatment durations (>41 days).

Conclusions:

• Amiodarone therapy is associated with a significantly increased risk of optic neuropathy.
• Male gender and longer treatment duration appear to be risk factors for amiodarone-induced optic neuropathy.
• Further research may be warranted to elucidate the precise mechanisms and optimize patient management.